Updates on the Management of Immunotherapy-Related Toxicities

1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

With the increased use of immune checkpoint inhibition (ICI) comes an increase in the number of patients being treated for immune-related adverse events (irAEs). At the NCCN 2023 Annual Conference, presenters discussed 3 different types of irAEs, namely immune-mediated pneumonitis, major adverse cardiac events including myocarditis and myositis/myasthenia gravis overlap syndrome, and oral toxicities including mucositis and sicca syndrome. They emphasized the importance of considering comorbidities and infectious causes when treating immune pneumonitis. In the context of cardiac events during ICI therapy, the presentation highlighted the need for early detection and vigilance in recognizing insidious, nonspecific symptoms, particularly in cases involving myocarditis with myositis/myasthenia gravis overlap syndrome. Finally, the increasing recognition of oral toxicities was discussed, in addition to the importance of timely intervention to prevent long-term morbidity.

References Powered by Scopus

Management of immune checkpoint blockade dysimmune toxicities: A collaborative position paper

750Citations
N/AReaders
Get full text

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment

318Citations
N/AReaders
Get full text

Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases

87Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Davies, M., McPherson, J., & Thompson, J. A. (2023). Updates on the Management of Immunotherapy-Related Toxicities. In JNCCN Journal of the National Comprehensive Cancer Network (Vol. 21, pp. 556–558). Harborside Press. https://doi.org/10.6004/jnccn.2023.5005

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

50%

Biochemistry, Genetics and Molecular Bi... 1

50%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free